Monday, December 31, 2018

Lupin gets USFDA nod for Clobazam Oral Suspension

Lupin gets USFDA nod for Clobazam Oral Suspension The drug is indicated for treatment of seizures associated with Lennox-Gastaut Syndrome (LGS) in patients of two years of age or older.

from Moneycontrol Business News http://bit.ly/2SzDNZX

No comments:

Post a Comment

Global Market Today: Asian stocks rise after tech-led rebound in US

Asian markets opened higher today. Technology shares led the gains, boosting Wall Street. This rally eased worries about artificial intellig...